Loading…
Reported covered position: Chief of Staff, Rep. Raul Ruiz; Chief of Staff, Rep. Jackie Speier; Deputy Chief of Staff, Rep. Mark Udall; Spec Assistant, Sen. Evan Bayh; Confidential Assistant, Office of Rural Development, USDA; Spec Assistant, Ofc of Political Affairs, White Hse
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
TRIA Act of 2021
Client: SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH · Firm: LINCOLN POLICY GROUP
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals H.R. 2455, The Resetting the Improving Medicare Post-Acute Transformation Act (IMPACT Act) of 2021; FY 2022 Inpatient Rehabilitation Facility (IRF) Prospective Payment System Proposed Rule and CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule
TRIA Act of 2021
Client: SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH · Firm: LINCOLN POLICY GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| 2 |
| 2021 |
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals H.R. 2455, The Resetting the Improving Medicare Post-Acute Transformation Act (IMPACT Act) of 2021; FY 2022 Inpatient Rehabilitation Facility (IRF) Prospective Payment System Proposed Rule and CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
2021 · third_quarter · 3T
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals H.R. 2455, The Resetting the Improving Medicare Post-Acute Transformation Act (IMPACT Act) of 2021; FY 2022 Inpatient Rehabilitation Facility (IRF) Prospective Payment System Proposed Rule and CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Q2
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals H.R. 2455, The Resetting the Improving Medicare Post-Acute Transformation Act (IMPACT Act) of 2021; FY 2022 Inpatient Rehabilitation Facility (IRF) Prospective Payment System Proposed Rule and CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Q1
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE